Nanologica AB

Nanologica operates in the field of nanotechnology. Currently the main business focus is on the sectors Drug Delivery and Chromatography, which includes the development of pharmaceutical administration and technology used for the separation and purification of products. The research is carried out in collaboration with Stockholm University and the Ångström Laboratory at Uppsala University. The company was founded in 2004 and is based in Södertälje.

Quotes for Nanologica AB

+/-
%
()

Board

CEO

  • Andreas Bhagwani

Chairperson of the Board

  • Gisela Sitbon

Board

  • Anders Rabbe
  • Eva Byröd
  • Lena Torlegård
  • Mattias Bengtsson
  • Thomas Eldered
  • Tomas Kramar
  • Articles of association

    • News

    Show More

    Analysis

    Videos

    Nanologica - Möt bolagen på Spotlight Next

    Nanologicas vd Andreas Bhagwani presenterar tredje kvartalet 2020

    Vd Andreas Bhagwani presenterar andra kvartalet 2020

    Presentation av Nanologica på Erik Penser Bank - 26 Juni 2020

    Largest Owners

    Name Capital % Votes % Date
    Flerie Invest AB 43,59 43,59 2025-12-23
    Ardena Sweden AB 17,50 17,50 2026-03-10
    Kungliga Konstakademien 4,82 4,82 2025-12-23
    Andreas Bhagwani 4,57 4,57 2025-12-23
    Avanza Pension 3,25 3,25 2025-12-23
    CJ Invest 2,36 2,36 2025-12-23
    Nordnet Pensionsförsäkring 2,23 2,23 2025-12-23
    Andre Oscar och Anna Wallenbergs stiftelse 2,08 2,08 2025-12-23
    Wallenbergska familjestiftelsen 0,80 0,80 2025-12-23
    Niklas Sjöblom 0,76 0,76 2025-12-23

    Annual reports, prospectus etc.